Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Restructuring Costs (2021 - 2022)

Biote has reported Restructuring Costs over the past 2 years, most recently at $1.2 million for Q1 2022.

  • Quarterly results put Restructuring Costs at $1.2 million for Q1 2022, up 1932.73% from a year ago — trailing twelve months through Mar 2022 was $4.3 million (changed N/A YoY), and the annual figure for FY2021 was $3.1 million, changed.
  • Restructuring Costs for Q1 2022 was $1.2 million at Biote, down from $2.3 million in the prior quarter.
  • Over the last five years, Restructuring Costs for BTMD hit a ceiling of $2.3 million in Q4 2021 and a floor of $58560.0 in Q1 2021.